In Vitro Antiviral Profile of AB-343, a Novel, Oral, Potent SARS-CoV-2 MproInhibitor with Pan-coronavirus Activity
ImQuest assisted with antiviral range of action analysis and SARS-CoV2 screening which was recently presented at ICAR 2023. Click Here to view.
Contact us to learn more about about our broad range of antiviral testing services.